Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

HeartSciences (HSCS) Gross Profit (2021 - 2025)

HeartSciences (HSCS) has disclosed Gross Profit for 5 consecutive years, with $1411.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Gross Profit changed N/A year-over-year to $1411.0, compared with a TTM value of $12690.0 through Oct 2025, changed N/A, and an annual FY2025 reading of $2470.0, down 80.27% over the prior year.
  • Gross Profit was $1411.0 for Q4 2025 at HeartSciences, up from $1140.0 in the prior quarter.
  • Across five years, Gross Profit topped out at $10139.0 in Q1 2024 and bottomed at $1140.0 in Q3 2025.
  • Average Gross Profit over 5 years is $2656.3, with a median of $1728.0 recorded in 2021.
  • The sharpest move saw Gross Profit tumbled 36.9% in 2023, then skyrocketed 752.02% in 2024.
  • Year by year, Gross Profit stood at $1728.0 in 2021, then tumbled by 32.64% to $1164.0 in 2022, then soared by 104.47% to $2380.0 in 2023, then soared by 326.01% to $10139.0 in 2024, then crashed by 86.08% to $1411.0 in 2025.
  • Business Quant data shows Gross Profit for HSCS at $1411.0 in Q4 2025, $1140.0 in Q3 2025, and $10139.0 in Q1 2024.